首页> 外国专利> Anti vegf-anti-pd1 dual specificity antibody of a novel structure

Anti vegf-anti-pd1 dual specificity antibody of a novel structure

机译:抗VEGF-抗PD1新颖结构的双特异性抗体

摘要

A new type of anti vegf-anti-pd1 dual specificity antibody is provided.Anti vegf-anti-pd1 dual specificity antibody of the new structure belongs to the technology of the molecular immunology.Cdr-h1 of the heavy chain variable region of the antibody is an amino acid sequence represented by SEQ ID No: 1, cdr-h2 is an amino acid sequence represented by SEQ ID No: 2, and CDR-H3 is an amino acid sequence expressed by SEQ ID NO Cdr-l of the light chain variable region of the antibody is an amino acid sequence represented by SEQ ID No: 4.The dual specificity antibody ps3vm isCan be effectively combined with PD-1 and VEGF proteinsIt effectively associates with PDL-1 and binds to the PD-1 proteinSimultaneously with VEGF-A, it can compete with VEGF protein effectively, andEffectively stimulating T cell functionCytokines IL-2 and IFN - γ Can be secretedIsotype control antibodyT cell proliferation and IL-2IFN γ Can not promote secretion.The dual specific antibody ps3vm can also positively inhibit tumor growth in mice.Diagram
机译:提供了一种新型的抗VEGF-抗PD1双特异性抗体。新结构的anti VEGF-抗PD1双特异性抗体属于抗体重链可变区的分子免疫学。CDR-H1的技术是由SEQ ID NO:1表示的氨基酸序列,CDR-H2是由SEQ ID NO:2表示的氨基酸序列,CDR-H3是由轻链的SEQ ID NO CDR-L表达的氨基酸序列抗体的可变区是由SEQ ID NO:4表示的氨基酸序列。与PD-1和VEGF蛋白质有效地将双重特异性抗体PS3VM ISCAN有效地与PDL-1相关联,并与VEGF与PD-1蛋白质突然结合-A,它可以有效地竞争VEGF蛋白,刺激性刺激的T细胞功能cytokines IL-2和IFN-γ可以是局部型对照抗体细胞增殖和IL-2IFNγ不能促进分泌。双重特异性抗体PS3VM也可以积极抑制肿瘤生长在小鼠.diagram

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号